Fig. 2: Human clinical data survey showing higher ERβ expression is associated with the poor prognosis in RCC patients. | Cell Death & Disease

Fig. 2: Human clinical data survey showing higher ERβ expression is associated with the poor prognosis in RCC patients.

From: Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC

Fig. 2

a Overall survival curve indicated higher levels of ERβ were associated with a worse survival rate (p < 0.001). b Overall survival curves indicated that male RCC patients with higher levels of ERβ had shorter survival rate (p = 0.007). c Overall survival curves indicated that female RCC patients with higher levels of ERβ had a lower survival rate (p < 0.012).

Back to article page